UPDATE: UBS Starts Gossamer Bio Inc. (GOSS) at Buy, PT $19, 'Diversified pipeline underappreciated'

April 6, 2022 6:27 AM EDT Send to a Friend
(Updated - April 6, 2022 6:29 AM EDT)

UBS analyst Eliana Merle initiates coverage on Gossamer Bio Inc. (NASDAQ ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login